First clinical data with VS-01 showcased in oral presentation at AASLD The Liver Meeting
Appointment of Leading Hepatologist Prof Dr Katharina Staufer as CMO
Agefi covers the U.S. FDA grant of Versantis latest Orphan Drug Designation
S&P Global Market Intelligence reports VS-01 Phase 1b data and speak about new ways to treat liver diseases.
Versantis selected among the Top25 best Scale-up companies in Switzerland
For the 5th year in a raw, Versantis ranks among Top100 best Swiss startups and was elected #2 BEST BIOTECH !
HOMEABOUT USDISEASE AREASPRODUCTSNEWSCAREERS
Versantis AGTechnoparkstrasse 1CH-8005 ZurichSwitzerland
Copyright © 2021Versantis AG